Immunity and the regulation of protein synthesis: surprising connections

Current Opinion in Immunology

Volumn 21, Issue 1, 2009, Pages 70-77

  Pierre, Philippe ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 2ALPHA; INITIATION FACTOR 4G; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA;

CELL SURVIVAL; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNITY; PLASTICITY; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; EUKARYOTIC INITIATION FACTORS; HUMANS; IMMUNITY, CELLULAR; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BIOSYNTHESIS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 64049100954     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.03.003     Document Type: Review

References (50)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Steinman R.M. Dendritic cells: understanding immunogenicity. Eur J Immunol 37 Suppl. 1 (2007) S53-S60
3. Steinman R.M. Lasker Basic Medical Research Award. Dendritic cells: versatile controllers of the immune system. Nat Med 13 (2007) 1155-1159
4. Pichlmair A., and Reis e Sousa C. Innate recognition of viruses. Immunity 27 (2007) 370-383
5. Yamasaki S., and Anderson P. Reprogramming mRNA translation during stress. Curr Opin Cell Biol 20 (2008) 222-226
6. Richter J.D., and Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433 (2005) 477-480
7. Sonenberg N., and Hinnebusch A.G. New modes of translational control in development, behavior, and disease. Mol Cell 28 (2007) 721-729
8. Sabatini D.M. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6 (2006) 729-734
9. Morley S.J., Coldwell M.J., and Clemens M.J. Initiation factor modifications in the preapoptotic phase. Cell Death Differ 12 (2005) 571-584
10. Holcik M., and Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6 (2005) 318-327
11. Sarkar S.N., Peters K.L., Elco C.P., Sakamoto S., Pal S., and Sen G.C. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11 (2004) 1060-1067
12. Lee M.S., and Kim Y.J. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76 (2007) 447-480
13. Lelouard H., Schmidt E.K., Camosseto V., Clavarino G., Ceppi M., Hsu H.T., and Pierre P. Regulation of translation is required for dendritic cell function and survival during activation. J Cell Biol 179 (2007) 1427-1439. This article links translation regulation with DC function and survival during the immune response. mRNA translation is regulated through the PI3K/mTOR pathway and the proteolysis of the translation initiation factors eIF4G 1 and DAP5 in several fragments capable of inhibiting cap-dependent translation. This inhibition correlates with major changes in the origin of the peptides presented by MHC class I and the ability of mature DCs to prevent cell death.
14. Schmidt EK, Clavarino G, Ceppi M, Wenger T, Pierre P: Surface sensing of translation, a non-radioactive method to monitor protein synthesis and cellular activation. Nat Methods, in press, doi:10.1038/nmeth.1314. This article describes 'SUnSET', a novel method to monitor mRNA translation by FACS. The performance of SUnSET is exemplified by showing that TCR stimulation by DCs increases strongly protein synthesis in primary T cells and that rapamycin does not inhibit this upregulation.
15. Fukao T., and Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 24 (2003) 358-363
16. Ohtani M., Nagai S., Kondo S., Mizuno S., Nakamura K., Tanabe M., Takeuchi T., Matsuda S., and Koyasu S. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112 (2008) 635-643
17. Turnquist H.R., Raimondi G., Zahorchak A.F., Fischer R.T., Wang Z., and Thomson A.W. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 178 (2007) 7018-7031. This article demonstrates that exposure to rapamycin affects the physiology of DCs, which loose most of their immunostimulatory capacity, but keep intact their ability to promote T regulatory cells induction.
18. Cao W., Manicassamy S., Tang H., Kasturi S.P., Pirani A., Murthy N., and Pulendran B. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 9 (2008) 1157-1164. This article shows that the rapamycin-sensitive PI(3)K-mTOR/p70 ribosomal S6 protein kinase (p70S6K) pathway is crucial for TLR-mediated induction of type I interferon in pDCs. Inhibition of mTOR or p70S6K by various approaches resulted in much less TLR-mediated production of interferon-α. The mechanism of this inhibition involves disruption of the TLR9-MyD88 complex and subsequent impairment of phosphorylation and nuclear translocation of IRF7.
19. Colina R., Costa-Mattioli M., Dowling R.J., Jaramillo M., Tai L.H., Breitbach C.J., Martineau Y., Larsson O., Rong L., Svitkin Y.V., et al. Translational control of the innate immune response through IRF-7. Nature 452 (2008) 323-328. This article shows that in mouse embryonic fibroblasts lacking the translational repressors 4E-BP1 and 4E-BP2, the threshold for eliciting type-I IFN production is lowered. Consequently, replication of several viruses is markedly suppressed. Furthermore, mice lacking 4E-BP1 and 4E-BP2 genes are resistant to vesicular stomatitis virus infection, and this correlates with an enhanced type-I IFN production in plasmacytoid dendritic cells.
20. Costa-Mattioli M., and Sonenberg N. RAPping production of type I interferon in pDCs through mTOR. Nat Immunol 9 (2008) 1097-1099
21. Yewdell J.W., Anton L.C., and Bennink J.R. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?. J Immunol 157 (1996) 1823-1826. In this review, Yewdell et al. formulate the DRiPS hypothesis.
22. Yewdell J.W., and Nicchitta C.V. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol 27 (2006) 368-373
23. Yewdell J.W., and Hickman H.D. New lane in the information highway: alternative reading frame peptides elicit T cells with potent antiretrovirus activity. J Exp Med 204 (2007) 2501-2504
24. Lelouard H., Gatti E., Cappello F., Gresser O., Camosseto V., and Pierre P. Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 417 (2002) 177-182. This paper is the first demonstration of DALIS formation during DC maturation and of the importance of DRiPs in this phenomenon.
25. Berglund P., Finzi D., Bennink J.R., and Yewdell J.W. Viral alteration of cellular translational machinery increases defective ribosomal products. J Virol 81 (2007) 7220-7229
26. Lelouard H., Ferrand V., Marguet D., Bania J., Camosseto V., David A., Gatti E., and Pierre P. Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J Cell Biol 164 (2004) 667-675
27. Schwab S.R., Li K.C., Kang C., and Shastri N. Constitutive display of cryptic translation products by MHC class I molecules. Science 301 (2003) 1367-1371. This paper shows that, in normal mouse cells, MHC I molecules can present a peptide encoded in the 3′ 'untranslated' region. Furthermore, this cryptic peptide is translated by a previously unknown mechanism that decodes the CUG initiation codon as leucine rather than the canonical methionine.
28. Schwab S.R., Shugart J.A., Horng T., Malarkannan S., and Shastri N. Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol 2 (2004) e366
29. Shastri N., Schwab S., and Serwold T. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 20 (2002) 463-493
30. Starck S., Ow Y., Jiang V., Tokuyama M., Rivera M., Qi X., Roberts R., and Shastri N. A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS ONE 3 (2008) 3460
31. Baugh J.M., and Pilipenko E.V. 20S proteasome differentially alters translation of different mRNAs via the cleavage of eIF4F and eIF3. Mol Cell 16 (2004) 575-586. This paper demonstrates that the proteasome is able to cleave several translation initation factors in vitro and favors IRES-mediated translation of several molecules.
32. Marash L., and Kimchi A. DAP5 and IRES-mediated translation during programmed cell death. Cell Death Differ 12 (2005) 554-562
33. Lewis S.M., and Holcik M. IRES in distress: translational regulation of the inhibitor of apoptosis proteins XIAP and HIAP2 during cell stress. Cell Death Differ 12 (2005) 547-553
34. Marash L., Liberman N., Henis-Korenblit S., Sivan G., Reem E., Elroy-Stein O., and Kimchi A. DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis. Mol Cell 30 (2008) 447-459
35. Vaux D.L., and Silke J. IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 6 (2005) 287-297
36. Warnakulasuriyarachchi D., Cerquozzi S., Cheung H.H., and Holcik M. Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. J Biol Chem 279 (2004) 17148-17157
37. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001) 255-258
38. Young L.J., Wilson N.S., Schnorrer P., Mount A., Lundie R.J., La Gruta N.L., Crabb B.S., Belz G.T., Heath W.R., and Villadangos J.A. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc Natl Acad Sci U S A 104 (2007) 17753-17758. This paper demonstrates DCs matured in vivo can still capture and process soluble antigens but are unable to present peptides derived from these antigens. Furthermore, presentation of viral antigens synthesized by the DCs themselves is also severely impaired. This immunosuppressed state could be reversed by adoptive transfer of DCs loaded exogenously with antigens, demonstrating that impairment of CD4 T cell responses was due to lack of antigen presentation rather than to overt suppression of T-cell activation. The biochemical mechanism underlying this phenomenon was the downregulation of MHC II-peptide complex synthesis that accompanied DC maturation.
39. Schroder M., and Kaufman R.J. The mammalian unfolded protein response. Annu Rev Biochem 74 (2005) 739-789
40. Cenci S., Mezghrani A., Cascio P., Bianchi G., Cerruti F., Fra A., Lelouard H., Masciarelli S., Mattioli L., Oliva L., et al. Progressively impaired proteasomal capacity during terminal plasma cell differentiation. EMBO J 25 (2006) 1104-1113
41. Iwakoshi N.N., Pypaert M., and Glimcher L.H. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J Exp Med 204 (2007) 2267-2275
42. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8 (2007) 519-529
43. Todd D.J., Lee A.H., and Glimcher L.H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 8 (2008) 663-674
44. Munn D.H., Sharma M.D., Baban B., Harding H.P., Zhang Y., Ron D., and Mellor A.L. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22 (2005) 633-642. This paper demonstrates the central role of the GCN2 stress kinase in sensing tryptophane depletion and arresting T cells in response to IDO. GCN2-knockout T cells were not inhibited by IDO-expressing DCs from tumor-draining lymph nodes. IDO induced profound anergy in responding wild-type T cells, but GCN2-knockout cells were refractory to IDO-induced anergy. GCN2 acts as a molecular sensor in T cells, allowing them to detect and respond to conditions created by IDO. Thus GCN2 and its target eIF2-α are key molecules for tolerance establishment and the subversion of the immune system by tumors.
45. Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117 (2007) 1147-1154
46. Sharma M.D., Baban B., Chandler P., Hou D.Y., Singh N., Yagita H., Azuma M., Blazar B.R., Mellor A.L., and Munn D.H. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117 (2007) 2570-2582
47. Scheu S., Stetson D.B., Reinhardt R.L., Leber J.H., Mohrs M., and Locksley R.M. Activation of the integrated stress response during T helper cell differentiation. Nat Immunol 7 (2006) 644-651. After priming via signals through the T-cell receptor, naive T helper cells express cytokine mRNA but do not secrete cytokine protein without additional T cell receptor stimulation. This article demonstrates that primed T cells phosphorylate the eukaryotic initiation factor 2-α and accumulate cytoplasmic granules associated with RNA-binding proteins. Restimulation of the cells resulted in rapid eIF2-α dephosphorylation, ribosomal mRNA loading, and cytokine secretion.
48. Fehniger T.A., Cai S.F., Cao X., Bredemeyer A.J., Presti R.M., French A.R., and Ley T.J. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26 (2007) 798-811. In this article, the role of eIF2-α phosphorylation in the acquisition of cytotoxic activity of mouse NK cells is demonstrated. Although activated murine NK cells can use the granule exocytosis pathway to kill target cells immediately upon recognition, resting murine NK cells are minimally cytotoxic. It is shown that resting murine NK cells are minimally cytotoxic because of a block in perforin and granzyme B mRNA translation that is released by NK cell activation.
49. Hsu L.C., Park J.M., Zhang K., Luo J.L., Maeda S., Kaufman R.J., Eckmann L., Guiney D.G., and Karin M. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428 (2004) 341-345
50. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., and Taganov K.D. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9 (2008) 839-845